EDELMAN JOSEPH 4

What Happened
Joseph Edelman, a director of LeonaBio, was granted a derivative award covering 28,000 shares on 2026-04-09. The Form 4 reports an acquisition at $0.00 per share (total reported value $0). This was a grant/award (not an open-market purchase or sale) — meaning no cash changed hands and no shares were immediately sold.

Key Details

• Transaction date: 2026-04-09; Form 4 filed 2026-04-13. (Note: Form 4s are generally due within two business days of the transaction; this filing is several days later than the transaction date.)
• Award: 28,000 shares reported as a derivative acquisition at $0.00 per share (total $0).
• Shares owned after transaction: Not specified in the filing.
• Footnote: The shares are subject to an option that vests monthly over 24 months on the monthly anniversaries of the grant date, contingent on continued service under the Issuer's 2026 Equity Incentive Plan.

Context
This is a grant of a derivative award (option/award) that vests over two years; it does not represent an immediate cash purchase or sale by the insider. Such awards are common for compensation and retention and should not be interpreted as a direct investment or divestment signal until shares vest or options are exercised.